You are here

  • Home
  • Archive
  • Volume 77, Issue Suppl 2
  • SAT0247 Impact of glucocorticoids on efficacy and safety of tofacitinib with and without methotrexate and adalimumab with methotrexate for rheumatoid arthritis: results from a phase 3b/4 randomised trial

Citation Tools

Article menu

Download PDFPDF

Saturday, 16 JUNE 2018
Rheumatoid arthritis - non biologic treatment and small molecules
SAT0247 Impact of glucocorticoids on efficacy and safety of tofacitinib with and without methotrexate and adalimumab with methotrexate for rheumatoid arthritis: results from a phase 3b/4 randomised trial
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Fleischmann R, Wollenhaupt J, Cohen S, et al
SAT0247 Impact of glucocorticoids on efficacy and safety of tofacitinib with and without methotrexate and adalimumab with methotrexate for rheumatoid arthritis: results from a phase 3b/4 randomised trial
Annals of the Rheumatic Diseases 2018;77:985-986.